125I-human epidermal growth factor specific binding to placentas and fetal membranes from various pregnancy states
- 1 April 1988
- journal article
- research article
- Published by Oxford University Press (OUP) in Acta Endocrinologica
- Vol. 117 (4) , 485-490
- https://doi.org/10.1530/acta.0.1170485
Abstract
Specific binding of 125I-human epidermal growth factor (hEGF) to homogenates of term human placentas and fetal membranes from normal and appropriate for gestational age (N = 20), intrauterine growth retarded (N = 9), twin (N = 11), White class A/B diabetic (N = 12), and large for gestational age (N = 13) pregnancies was measured. In all pregnancy states, placentas bound approximately four times more 125I-hEGF than did fetal membranes (P < 0.001). There was no significant difference in 125I-hEGF binding to fetal membranes from the various pregnancy states (P > 0.05). 125I-hEGF specific binding to placentas from intrauterine growth retarded or twin pregnancies was significantly greater compared with placentas from normal and appropriate for gestational age pregnancies (P < 0.05). The binding to placentas from pregnancies complicated by White class A/B diabetes or large for gestational age infants, on the other hand, was not significantly different from that to placentas from normal and appropriate for gestational age pregnancies. 125I-hEGF specific binding did not differ between placentas from intrauterine growth retarded or twin pregnancies (P > 0.05). Placental and fetal membrane 125I-hEGF binding did not vary with fetal sex, maternal race, placental weight, or gestational age between 37 to 42 weeks (P > 0.05). Placental but not fetal membrane 125I-hEGF binding increased with increasing infant weight when appropriate for gestational age and large for gestational age infants were included (P < 0.05, r = 0.38, N = 32) but not for intrauterine growth retarded, appropriate for gestational age, or large for gestational age infants alone.This publication has 10 references indexed in Scilit:
- Epidermal Growth Factor in Urine of Nonpregnant Women and Pregnant Women Throughout Pregnancy and At Delivery*Journal of Clinical Endocrinology & Metabolism, 1988
- Induction of Differentiated Trophoblast Function by Epidermal Growth Factor: Relation of Immunohistochemically Detected Cellular Epidermal Growth Factor Receptor Levels*Journal of Clinical Endocrinology & Metabolism, 1987
- Levels of epidermal growth factor binding in third-trimester and term human placentas: Elevated binding in term placentas of male fetusesAmerican Journal of Obstetrics and Gynecology, 1987
- Epidermal Growth Factor Binding to Human Amnion, Chorion, Decidua, and Placenta from Mid- and Term Pregnancy: Quantitative Light Microscopic Autoradiographic StudiesJournal of Clinical Endocrinology & Metabolism, 1985
- Topography of human placental receptors for epidermal growth factor.Journal of Biological Chemistry, 1985
- Binding Sites for Epidermal Growth Factor in Human Fetal MembranesJournal of Clinical Endocrinology & Metabolism, 1984
- Binding Sites for Epidermal Growth Factor in Human Uterine Tissues and LeiomyomasJournal of Clinical Endocrinology & Metabolism, 1984
- Ontogenesis and characteristics of epidermal growth factor receptors in human placentaAmerican Journal of Obstetrics and Gynecology, 1983
- EPIDERMAL GROWTH FACTOR STIMULATES PRODUCTION OF PROGESTERONE IN CULTURED HUMAN CHORIOCARCINOMA CELLSEndocrinology, 1980
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951